Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine.
| Předmět: | |
|---|---|
| Zdroj: | Saudi Medical Journal; Aug2022, Vol. 43 Issue 8, p972-973, 2p |
| Abstrakt: | The article discusses people with hematologic malignancies, blood cancers including leukemia, lymphoma, and multiple myeloma have an impaired immune system due to their disease and its treatment. Topics include vaccination with one of three U.S. Food and Drug Administration (FDA)-authorized COVID-19 vaccines, and patients with active cancer or those recently treated with an immune cell–depleting therapy were least likely to produce these antibodies. |
| Databáze: | Complementary Index |
| Externí odkaz: |
|